Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This is a Phase 2, single-arm, open-label study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cancer.
Sponsor: Corcept Therapeutics
Check if you qualify for this ovarian cancer clinical trial in Palo Alto, CA
If you're searching for ovarian cancer treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.